Transcriptome bioinformatic analysis identifies potential therapeutic mechanism of pentylenetetrazole in down syndrome

BACKGROUND: Pentylenetetrazole (PTZ) has recently been found to ameliorate cognitive impairment in rodent models of Down syndrome (DS). The mechanism underlying PTZ's therapeutic effect in DS is however not clear. Microarray profiling has previously reported differential expression, both up- an...

Descripción completa

Detalles Bibliográficos
Autor principal: Sharma, Abhay
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987760/
https://www.ncbi.nlm.nih.gov/pubmed/21029440
http://dx.doi.org/10.1186/1756-0381-3-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987760/
https://www.ncbi.nlm.nih.gov/pubmed/21029440
http://dx.doi.org/10.1186/1756-0381-3-7

Ejemplares similares